High Incidence of Naevi-associated BRAF Wild-type Melanoma and Dysplastic Naevi under Treatment with the Class I BRAF Inhibitor Vemurafenib

Authors
Publication date
1 January 2014
Publisher
Medical Journals Sweden AB
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      oaiinfo:doi/10.2340%2F00015555-18...
      Last time updated on 21/04/2021